Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
伊沙妥昔单抗联合卡非佐米、来那度胺和地塞米松治疗高危新诊断多发性骨髓瘤患者的简明语言摘要
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2402639
Leypoldt, Lisa B; Tichy, Diana; Besemer, Britta; Hanel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Gorner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Pozek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C